-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on United Therapeutics, Raises Price Target to $348

Benzinga·05/01/2025 17:39:15
Listen to the news
Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $346 to $348.